搜索

News Center
Expert consensus: Livzon Antiviral Granules are recommended for mild and common infections of COVID-19

A Recombinant SARS-Cov-2 Fusion Protein Vaccine (V-01) developed and manufactured by Livzon has shown good protective effects against the Omicron variant in a phase III clinical booster trial

Livzon Pharmaceutical Group was recognized as the National Enterprise Technology Center with High Scores

Environmental,Social and Governance Report 2019

medical insurance system has been gradually established and major health indicators of the residen
medical insurance system has been gradually established and major health indicators of the residen
Zhu Baoguo Won the TNC Oak Leaf Award

2018-12-26
Previous page
1
2
3
4
5
6
Next page
Add: No.38, Chuangye North Road, Jinwan District, Zhuhai, Guangdong, P.R.China Tel: 0756-8135888
©2021 Livzon 粤ICP备05025993-4号 Support:300.cn
Add: No.38, Chuangye North Road, Jinwan District, Zhuhai, Guangdong, P.R.China
©2021 Livzon 粤ICP备05025993号
Support:300.cn